USPTO serial 79242391
MYCOSAFE
Reviewed by CopyMark Law Group
Reg. 5772221Status 706Registered
- Filing date
- Status date
- Registration date
- Jun 11, 2019
- Examiner
- ROACH, APRIL K
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with MYCOSAFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael Fedrick
Michael Fedrick Loza & Loza, LLP305 N. Second Ave. #127Upland, CA 91786-6064United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals and biological reagents used in industry and science other than for medical and veterinary use; reagents for quality control, for diagnostics, and for scientific purposes, other than for medical and veterinary use, in particular mycoplasma culture media, mycoplasma culture and DNA reference standards, mycoplasma detection assays based on nucleic acid amplification techniques [ , and mycoplasma elimination reagents ] | ACTIVE | — |
| 042 | [ Scientific and technological services, namely biological sample testing and diagnosis for scientific purposes, biological sample testing for quality control purposes, and research and design in the field of biologicals and biopharmaceutical reagents; analytical and research services, namely analysis of biological samples, research and development of reagents for analytical use in the field of mycoplasmology, and research and development of standards for analytical use in the field of mycoplasmology; services for mycoplasma testing and test validation, namely, quality control of biological and biopharmaceutical products, and quality assurance of biological and biopharmaceutical products; ] consulting services in the scientific, technological and research field of mycoplasmology, in particular in mycoplasma detection, prevention and control | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Renate Rosengarten
- Other trademarks owned by Renate Rosengarten
- Other trademarks owned by Renate Rosengarten
- Other trademarks in Class 001
- Other trademarks in Class 042
- Similar marks named MYCOSAFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 14, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 14, 2026 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Apr 6, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 9, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 11, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 12, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 23, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 23, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 11, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 11, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 23, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 6, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 4, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 31, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 30, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 29, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 4, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |